why choose us

First received: May 04, 2023

Clinical Trial: Immune Spatial Features of Guselkumab Cutaneous Response

Study Status: Completed

Recruit Status: RECRUITING

Condition: Psoriasis of Scalp

Study Type: INTERVENTIONAL


Official Title: Immune Spatial Features of Guselkumab Cutaneous Response

Brief Summary: This study examines the effect of IL-23 blockade with Guselkumab on the immune cells of scalp psoriasis lesions.

Read more